Founded in science.
Focused on people.
Pioneering lipoprotein-receptor drug development to repair damage and degeneration of the brain, spinal cord and beyond.
Our vision
Our mission is to develop innovative therapies to restore independence and improve patient's lives. We meticulous explore every option to maximize benefits such as multi-modality discovery and optimized drug delivery . We believe that while the “fail fast” model can avoid costly false positives, our responsibility to patients is to avoid false negatives to ensure that we deliver the best possible therapies, and not be limited by the perception of “good enough”.
First-in-class therapies to promote neurological health and repair
Proteinopathies
Developing small molecule therapies to block spread of prion-like proteins, resulting in the prevention of neurodegeneration and cognitive decline. Learn more.
Neuroregeneration
Enhancing the regenerative capacity of the spinal cord following traumatic injury. Learn more.